Jennifer G. Abelin

发表

Specter: linear deconvolution as a new paradigm for targeted analysis of data-independent acquisition mass spectrometry proteomics

Michael J MacCoss, Steven A Carr, Jacob D. Jaffe, 2017, bioRxiv.

Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes*

Aravind Subramanian, Steven A Carr, Susan E. Abbatiello, 2016, Molecular & Cellular Proteomics.

MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

Jennifer G. Abelin, J. Shabanowitz, D. Hunt, 2013, Science Translational Medicine.

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

Jennifer G. Abelin, Ying S. Ting, Michael S. Rooney, 2019, Immunity.

Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction

Jennifer G. Abelin, N. Hacohen, S. Carr, 2017, Immunity.

The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction

Jennifer G. Abelin, Ying S. Ting, Michael S. Rooney, 2018, Proteomics.

A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations

Michael J. MacCoss, Brendan X. MacLean, Todd R. Golub, 2017, bioRxiv.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs

Jennifer G. Abelin, Pardis C Sabeti, N. Hacohen, 2020, bioRxiv.

A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations

Jacob K. Asiedu, Ted E. Natoli, Jennifer G. Abelin, 2017, bioRxiv.

Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations

Jennifer G. Abelin, M. V. van Buuren, Michael S. Rooney, 2021, Cell reports methods.

MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues

Jennifer G. Abelin, M. Gillette, Susan Klaeger, 2021, bioRxiv.

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Jennifer G. Abelin, N. Hacohen, D. Keskin, 2021, Cell.

MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies

Jennifer G. Abelin, S. Carr, Susan Klaeger, 2021, Molecular & cellular proteomics : MCP.

Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes

Steven A Carr, Moran Yassour, Jennifer G Abelin, 2018, Nature Medicine.

Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples

Jennifer G. Abelin, N. Hacohen, D. Keskin, 2021, Molecular & cellular proteomics : MCP.

Optimized liquid and gas phase fractionation increase HLA-peptidome coverage for primary cell and tissue samples

Jennifer G. Abelin, N. Hacohen, D. Keskin, 2021, bioRxiv.

Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer

Jennifer G. Abelin, J. Shabanowitz, D. Hunt, 2021, Frontiers in Immunology.

Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.

Jennifer G. Abelin, Ying S. Ting, Michael S. Rooney, 2021, Immunity.

Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry

Mark Cobbold, Jennifer G Abelin, Jennifer G. Abelin, 2015, Nature Protocols.

HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses

Jennifer G. Abelin, Pardis C Sabeti, D. Keskin, 2022, STAR protocols.

Cobbold Memory-like Immunity in Leukemia Associated Phosphopeptides Are the Targets of − MHC Class

Jennifer G. Abelin, J. Shabanowitz, D. Hunt, 2013 .

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues

Jennifer G. Abelin, M. Gillette, Susan Klaeger, 2023, Nature Communications.

Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry

Jennifer G. Abelin, Alvaro Sebastian Vaca Jacome, Susan Klaeger, 2023, bioRxiv.

What can Ribo-seq and proteomics tell us about the non-canonical proteome?

Jonathan M. Mudge, Jennifer G. Abelin, E. Deutsch, 2023, bioRxiv.

Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes

Jennifer G. Abelin, Daniel J. O'Connell, M. Yassour, 2018, Nature Medicine.

Specter: linear deconvolution for targeted analysis of data-independent acquisition mass spectrometry proteomics

Michael J MacCoss, Steven A Carr, Jacob D. Jaffe, 2018, Nature Methods.

The HLA-II immunopeptidome of SARS-CoV-2

Jennifer G. Abelin, Pardis C Sabeti, N. Hacohen, 2023, bioRxiv.

HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery.

Jennifer G. Abelin, D. Plichta, R. Xavier, 2023, Immunity.

Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry

Alvaro Sebastian Vaca Jacome, Jennifer G. Abelin, S. Carr, 2023, Molecular & cellular proteomics : MCP.

What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?

Jonathan M. Mudge, Jennifer G. Abelin, R. Moritz, 2023, Molecular & cellular proteomics : MCP.

MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

Jennifer G. Abelin, J. Shabanowitz, D. Hunt, 2013, Science Translational Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Pan-cancer proteogenomics characterization of tumor immunity

Jeffrey R. Whiteaker, Matthew A. Wyczalkowski, Ratna R. Thangudu, 2024, Cell.

Pan-viral ORFs discovery using Massively Parallel Ribosome Profiling

Jennifer G. Abelin, Susan Klaeger, K. Clauser, 2023, bioRxiv.

Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry

Alvaro Sebastian Vaca Jacome, Jennifer G. Abelin, S. Carr, 2023, Molecular & cellular proteomics : MCP.